标题
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 13, Issue 2, Pages 119-132
出版商
Springer Nature
发表日期
2015-09-01
DOI
10.1038/nrclinonc.2015.146
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Reliability of the Xpert HPV Assay to Detect High-Risk Human Papillomavirus DNA in a Colposcopy Referral Population
- (2015) Philip E. Castle et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Distinct demographic factors influence the acceptance of vaccination against HPV
- (2015) Theodoros Agorastos et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Safety of human papillomavirus vaccines: a review
- (2015) Michela Stillo et al. Expert Opinion On Drug Safety
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
- (2015) Mélanie Drolet et al. LANCET INFECTIOUS DISEASES
- Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma
- (2015) Wenjun Liao et al. MEDICINE
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening
- (2015) Warner K. Huh et al. OBSTETRICS AND GYNECOLOGY
- Acceptability of human papillomavirus vaccines among women older than 26 years
- (2015) Amanda F. Dempsey et al. VACCINE
- Organization and quality of HPV vaccination programs in Europe
- (2015) K. Miriam Elfström et al. VACCINE
- Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012
- (2015) Susan Hariri et al. VACCINE
- Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial
- (2015) Matti Lehtinen et al. VACCINE
- Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
- (2015) M. Jit et al. BMJ-British Medical Journal
- Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
- (2015) M. Jit et al. BMJ-British Medical Journal
- Cervical cancer screening: on the way to a shift from cytology to full molecular screening
- (2014) M. G. Dijkstra et al. ANNALS OF ONCOLOGY
- 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence
- (2014) S Vaccarella et al. BRITISH JOURNAL OF CANCER
- The Australian Experience With the Human Papillomavirus Vaccine
- (2014) Suzanne M. Garland CLINICAL THERAPEUTICS
- The road ahead for cervical cancer prevention and control
- (2014) J.E. Tota et al. Current Oncology
- Large contribution of human papillomavirus in vaginal neoplastic lesions: A worldwide study in 597 samples
- (2014) L. Alemany et al. EUROPEAN JOURNAL OF CANCER
- Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: Baseline and longitudinal data
- (2014) Margot H. Uijterwaal et al. INTERNATIONAL JOURNAL OF CANCER
- Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide
- (2014) Laia Alemany et al. INTERNATIONAL JOURNAL OF CANCER
- A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results
- (2014) M. Schiffman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions
- (2014) Jack Cuzick et al. JOURNAL OF CLINICAL VIROLOGY
- The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens
- (2014) Wen Chen et al. JOURNAL OF CLINICAL VIROLOGY
- Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA
- (2014) Xavier Castellsagué et al. JOURNAL OF INFECTIOUS DISEASES
- Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia--Nationwide Follow-up of Young Danish Women
- (2014) B. Baldur-Felskov et al. JNCI-Journal of the National Cancer Institute
- Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
- (2014) S Rachel Skinner et al. LANCET
- Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
- (2014) Sepehr N Tabrizi et al. LANCET INFECTIOUS DISEASES
- Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
- (2014) Marc Arbyn et al. LANCET ONCOLOGY
- Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial
- (2014) Viola M J Verhoef et al. LANCET ONCOLOGY
- Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys
- (2014) Emily A. Burger et al. PLoS One
- Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis
- (2014) N. Pathak et al. BMJ-British Medical Journal
- Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
- (2014) Alejandra Castañón et al. PLOS MEDICINE
- Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model
- (2014) Iacopo Baussano et al. Infectious Agents and Cancer
- Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
- (2013) Jane J. Kim ANNALS OF INTERNAL MEDICINE
- Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
- (2013) Dorota M Gertig et al. BMC Medicine
- Age-Specific Occurrence of HPV16- and HPV18-Related Cervical Cancer
- (2013) S. de Sanjose et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors
- (2013) Salvatore Vaccarella et al. EUROPEAN JOURNAL OF CANCER
- Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva
- (2013) Silvia de Sanjosé et al. EUROPEAN JOURNAL OF CANCER
- Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)?
- (2013) Woo Dae Kang et al. GYNECOLOGIC ONCOLOGY
- Specimen self-collection and HPV DNA screening in a pilot study of 100,242 women
- (2013) Eduardo Lazcano-Ponce et al. INTERNATIONAL JOURNAL OF CANCER
- Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland
- (2013) Heini Salo et al. INTERNATIONAL JOURNAL OF CANCER
- The burden and costs of prevention and management of genital disease caused by HPV in women: A population-based registry study in Finland
- (2013) Heini Salo et al. INTERNATIONAL JOURNAL OF CANCER
- Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with “low-risk” HPV genotypes 6 and 11
- (2013) Alyssa M. Cornall et al. INTERNATIONAL JOURNAL OF CANCER
- Interlaboratory variation in the performance of liquid-based cytology: Insights from the ATHENA trial
- (2013) Thomas C. Wright et al. INTERNATIONAL JOURNAL OF CANCER
- Lower cost strategies for triage of human papillomavirus DNA-positive women
- (2013) You-Lin Qiao et al. INTERNATIONAL JOURNAL OF CANCER
- Benefits of catch-up in vaccination against human papillomavirus in medium- and low-income countries
- (2013) Iacopo Baussano et al. INTERNATIONAL JOURNAL OF CANCER
- Model-Based Estimates of Long-Term Persistence of Induced HPV Antibodies: A Flexible Subject-Specific Approach
- (2013) Mehreteab Aregay et al. Journal of Biopharmaceutical Statistics
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- Clinical trials of human papillomavirus vaccines and beyond
- (2013) Matti Lehtinen et al. Nature Reviews Clinical Oncology
- Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
- (2013) Rolando Herrero et al. PLoS One
- Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine
- (2013) Hugo C. Turner et al. PLoS One
- Recommendations for Cervical Cancer Prevention in Central and Eastern Europe and Central Asia
- (2013) Mario Poljak et al. VACCINE
- Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England
- (2013) D. Mesher et al. VACCINE
- Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium
- (2013) Nadia Demarteau et al. VACCINE
- Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing
- (2012) M Hendry et al. BRITISH JOURNAL OF CANCER
- Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
- (2012) Peng Guan et al. INTERNATIONAL JOURNAL OF CANCER
- Cervical Cancer Screening in the United States and the Netherlands: A Tale of Two Countries
- (2012) DIK HABBEMA et al. MILBANK QUARTERLY
- Upgrading Public Health Programs for Human Papillomavirus Prevention and Control is Possible in Low- and Middle-income Countries
- (2012) Marc Steben et al. VACCINE
- Global Burden of Human Papillomavirus and Related Diseases
- (2012) David Forman et al. VACCINE
- New Technologies and Procedures for Cervical Cancer Screening
- (2012) Jack Cuzick et al. VACCINE
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
- (2012) Marc Arbyn et al. VACCINE
- Human Papillomavirus Vaccine Introduction – The First Five Years
- (2012) Lauri E. Markowitz et al. VACCINE
- Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study
- (2011) TRACY T.C. KWAN et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- End-of-study safety, immunogenicity and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
- (2011) X Castellsagué et al. BRITISH JOURNAL OF CANCER
- Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology
- (2011) K. Ulrich Petry et al. GYNECOLOGIC ONCOLOGY
- The known unknowns of HPV natural history
- (2011) Patti E. Gravitt JOURNAL OF CLINICAL INVESTIGATION
- Until Which Age Should Women Be Vaccinated Against HPV Infection? Recommendation Based on Cost-effectiveness Analyses
- (2011) Tjalke A. Westra et al. JOURNAL OF INFECTIOUS DISEASES
- Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
- (2011) Dorien C Rijkaart et al. LANCET ONCOLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
- (2011) Anna R. Giuliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
- (2011) Joel M. Palefsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine
- (2011) Rebecca Anhang Price et al. VACCINE
- The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands
- (2011) Johannes A. Bogaards et al. VACCINE
- Human Papillomavirus Vaccine Among Adult Women
- (2010) Yan Cui et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Human Papillomavirus Infection and Reinfection in Adult Women: the Role of Sexual Activity and Natural Immunity
- (2010) H. Trottier et al. CANCER RESEARCH
- A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer
- (2010) Nadia Demarteau et al. International Journal of Public Health
- Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark
- (2010) Jens Olsen et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings
- (2010) Laia Bruni et al. JOURNAL OF INFECTIOUS DISEASES
- Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
- (2010) A. C. Rodriguez et al. JNCI-Journal of the National Cancer Institute
- Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
- (2010) S. K. Kjaer et al. JNCI-Journal of the National Cancer Institute
- Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
- (2010) M. Safaeian et al. JNCI-Journal of the National Cancer Institute
- Factors affecting transmission of mucosal human papillomavirus
- (2010) Nienke J Veldhuijzen et al. LANCET INFECTIOUS DISEASES
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
- (2010) Guglielmo Ronco et al. LANCET ONCOLOGY
- The cost effectiveness of a quadrivalent human papillomavirus vaccine (6/11/16/18) in Hungary
- (2010) Erik J. Dasbach et al. JOURNAL OF MEDICAL ECONOMICS
- The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change
- (2009) Eduardo L. Franco et al. ARCHIVES OF MEDICAL RESEARCH
- Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆
- (2009) Marie-Pierre David et al. GYNECOLOGIC ONCOLOGY
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
- (2009) Maarit Leinonen et al. JNCI-Journal of the National Cancer Institute
- Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial
- (2009) Nubia Muñoz et al. LANCET
- HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
- (2009) Henry C Kitchener et al. LANCET ONCOLOGY
- HPV Screening for Cervical Cancer in Rural India
- (2009) Rengaswamy Sankaranarayanan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Based Programs for Vaccination against HPV
- (2009) Elamin H. Elbasha et al. VALUE IN HEALTH
- The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK
- (2008) EJ Dasbach et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study
- (2008) Jack Cuzick et al. INTERNATIONAL JOURNAL OF CANCER
- Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
- (2008) Francesca Carozzi et al. LANCET ONCOLOGY
- Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
- (2008) Margaret RE McCredie et al. LANCET ONCOLOGY
- Health and Economic Implications of HPV Vaccination in the United States
- (2008) Jane J. Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model
- (2008) Cara Usher et al. VACCINE
- Modeling Cervical Cancer Prevention in Developed Countries
- (2008) Jane J. Kim et al. VACCINE
- Assessment of the cost–effectiveness of a quadrivalent HPV vaccine in Norway using a dynamic transmission model
- (2008) Erik J Dasbach et al. Expert Review of Pharmacoeconomics & Outcomes Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More